AMAG Pharmaceuticals Inc. (AMAG)

24.45 0 (0%)

IEX Real-Time Price

August 16, 2018 EST.

Nasdaq Global Select : Healthcare

Prev Close 24.45

Price Open 24.95

Volume: 515,134

Avg Volume: 555,369

Market Cap: 842.86M

P/E Ratio -36.49

52 Wk Range 11.925-26.1



AMAG Short Interest Statistics


Report Date
Float Share
Short Interest
Short Ratio
Short % to Float

2018-07-31
32.91M
11.35M
21.63
34.48%

2018-07-13
32.77M
10.84M
11.31
33.07%

2018-06-29
32.77M
11.07M
11.85
33.80%

2018-06-15
32.77M
10.91M
15.18
33.29%




AMAG Earning Report


Report Date
Fiscal Period
Announce Time
Estimated EPS(#)
Actual EPS
Surprise Dollar

2018-05-03
Q1 2018
BTO
-0.49 (4)
-1.59
-1.10

2018-05-01
Q1 2018
N/A
-0.48 (4)
0.00
0.00

2018-02-27
Q4 2017
N/A
-0.38 (4)
0.10
0.68

2018-02-20
Q4 2017
N/A
-0.33 (3)
0.10
0.68

News

California Cryobank And Cord Blood Registry Combine To Create A Leading Life Sciences Platform (2018-08-06 16:45 PR Newswire)

LOS ANGELES , Aug. 6, 2018 /PRNewswire/ -- California Cryobank , the world's leading donor sperm and donor egg bank, announced today that it has been acquired by GI Partners, a private equity investment firm, from leading healthcare investors Longitude Capital and NovaQuest Capital….

 


Statistics

Shares Outstanding: 34.47M

Top 15 Institution Percent: N/A

Price To Sales: 1.41

Price To Book: 1.18

Revenue: 153.74M

Gross Profit: 117.10M

Cash: 394.10M

Debt: 755.42M

Return On Assets: -10.75

Return On Equity: -26.63

Profit Margin: -36.87

Price History

Beta: 0.44

50-day Moving Avg: 22.60

200-day Moving Avg: 18.89

YTD Change: 67.47

5-day Change: -4.68

1-month Change: 12.93

3-month Change: 1.66

6-month Change: 32.16

1-year Change: 40.11

Revenue Per Share: 4.00

Revenue Per Employee: 201760.00



Dividend

Dividend Yield: -

EX-Dividend Date: -

Dividend Rate: -


Company Profile

Name: AMAG Pharmaceuticals Inc.

Exchange: Nasdaq Global Select

Industry: Biotechnology

Sector: Healthcare

Website: http://www.amagpharma.com

AMAG Pharmaceuticals Inc is a biopharmaceutical company, which utilizes the technology for the development and commercialization of a therapeutic iron compound to treat iron deficiency anemia and to aid in the diagnosis of cancer.